Answer
Linzagolix is a selective, non-peptide GnRH receptor antagonist that competitively binds pituitary GnRH receptors, inhibiting endogenous GnRH signalling and modulating the hypothalamic-pituitary-gonadal axis.
Sources for this answer
- Yselty 100mg film-coated tabletsTheramex · emc · SmPC §5.1 Pharmacodynamic properties · Version 2Document updated
Sources checked